New York State Teachers Retirement System decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 6.0% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 582,490 shares of the real estate investment trust's stock after selling 37,461 shares during the quarter. New York State Teachers Retirement System owned 0.08% of Healthpeak Properties worth $11,778,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of DOC. Douglas Lane & Associates LLC raised its position in shares of Healthpeak Properties by 8.5% during the first quarter. Douglas Lane & Associates LLC now owns 2,792,850 shares of the real estate investment trust's stock worth $56,471,000 after purchasing an additional 218,395 shares during the period. Cambridge Investment Research Advisors Inc. raised its holdings in Healthpeak Properties by 6.9% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust's stock worth $7,229,000 after buying an additional 23,135 shares during the period. Ibex Wealth Advisors purchased a new stake in Healthpeak Properties during the first quarter valued at about $5,056,000. Vert Asset Management LLC boosted its holdings in shares of Healthpeak Properties by 6.9% in the first quarter. Vert Asset Management LLC now owns 325,143 shares of the real estate investment trust's stock worth $6,574,000 after buying an additional 20,924 shares during the period. Finally, Two Sigma Advisers LP purchased a new position in shares of Healthpeak Properties in the fourth quarter worth approximately $5,691,000. Institutional investors own 93.57% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently commented on DOC shares. Wells Fargo & Company reduced their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Wall Street Zen raised Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Sunday, June 29th. Robert W. Baird reduced their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Argus reissued a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Finally, Wedbush dropped their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $23.27.
View Our Latest Report on Healthpeak Properties
Healthpeak Properties Stock Performance
DOC traded down $0.07 on Friday, hitting $18.25. The company had a trading volume of 5,546,828 shares, compared to its average volume of 5,320,639. The stock has a market cap of $12.68 billion, a price-to-earnings ratio of 45.61, a price-to-earnings-growth ratio of 2.09 and a beta of 1.03. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.35 and a quick ratio of 1.35. The company's fifty day moving average price is $17.42 and its 200 day moving average price is $19.03. Healthpeak Properties, Inc. has a 1-year low of $16.64 and a 1-year high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting analysts' consensus estimates of $0.46. The firm had revenue of $702.89 million during the quarter, compared to analyst estimates of $690.76 million. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The business's revenue was up 15.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.45 EPS. Equities analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The firm also recently declared a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were issued a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, May 19th. This represents a dividend yield of 7.05%. Healthpeak Properties's dividend payout ratio (DPR) is presently 305.00%.
Insider Transactions at Healthpeak Properties
In related news, CEO Scott M. Brinker acquired 11,337 shares of the company's stock in a transaction dated Monday, April 28th. The shares were bought at an average price of $17.68 per share, for a total transaction of $200,438.16. Following the acquisition, the chief executive officer owned 201,863 shares in the company, valued at $3,568,937.84. This trade represents a 5.95% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director John T. Thomas purchased 4,200 shares of the stock in a transaction that occurred on Monday, April 28th. The shares were purchased at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the purchase, the director directly owned 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This trade represents a 0.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired a total of 29,764 shares of company stock worth $521,909 over the last three months. 0.23% of the stock is currently owned by insiders.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.